- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01728896
Patient-Initiated and ConTrolled Oral Refeeding (PICTOR) (PICTOR)
A Randomized Controlled Trial of Patient-Initiated and ConTrolled Oral Refeeding in Acute Pancreatitis
The first step in treating patients with acute pancreatitis is to provide pain relief and intravenous fluids to keep them comfortable. As the pain subsides and patient starts to feel better food and fluids by mouth are restarted. This is done to rest the pancreas which is the organ that has been inflamed.
In some patients when food by mouth restarts they have pain and as a consequence they have a longer stay in hospital. It is thought that patients who have little pain and are within 24 hours of admission to hospital do well if they control their own food intake. This is in contrast to the usual treatment where the treating team advise when eating should restart.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Auckland, New Zealand
- University of Auckland; Auckland City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of acute pancreatitis
- age > 18 years
- written informed consent
Exclusion Criteria:
- ongoing need for opiates
- >96 hours after onset of symptoms
- chronic pancreatitis
- post-ERCP pancreatitis
- intraoperative diagnosis
- pregnancy
- malignancy
- received nutrition before randomisation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Conventional management
|
|
Experimental: Patient-controlled oral refeeding
Patients will be allowed to drink and eat hospital food freely as tolerated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Oral food intolerance
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time from admission until tolerance of oral food
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Total length of hospital stay
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Need for opiates
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Need for opiates is defined when one (or more) of the following has been administered:
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Change in pain intensity
Time Frame: Baseline and 24, 48, 72h after randomisation
|
Baseline and 24, 48, 72h after randomisation
|
|
Progression of acute pancreatitis severity
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
To be defined according to the 2012 determinant-based classification of acute pancreatitis severity
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Hospital readmission
Time Frame: 2 weeks after hospital discharge
|
2 weeks after hospital discharge
|
|
Local and systemic complications
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
To be defined according to the 2012 determinant-based classification of acute pancreatitis severity
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Number and type of interventions during hospital stay
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Time from admission until first flatus
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
Participants will be followed for the duration of hospital stay, an expected average of 7 days
|
|
Change in blood glucose
Time Frame: Baseline and 24, 48, 72h after randomisation
|
Baseline and 24, 48, 72h after randomisation
|
|
Change in plasma C-reactive protein
Time Frame: Baseline and 24, 48, 72h after randomisation
|
Baseline and 24, 48, 72h after randomisation
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NTX/12/06/051
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Pancreatitis
-
Centre Hospitalier Universitaire de NiceRecruiting
-
John Gasdal KarstensenCompleted
-
Tianjin Nankai HospitalCompletedAcute PancreatitisChina
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedAcute Pancreatitis (AP) | Gallstone Pancreatitis | Alcoholic Pancreatitis | Trauma Acute Pancreatitis | Hypertriglyceridemia Acute Pancreatitis | Idiopathic (Unknown) Acute Pancreatitis | Medication Induced Acute Pancreatitis | Cancer Acute Pancreatitis | Miscellaneous (i.e. Acute on Chronic Pancreatitis)United States
-
Northern State Medical UniversityCompleted
-
Erzhen ChenRenJi HospitalUnknownPancreatitis,Acute NecrotizingChina
-
Orlando Health, Inc.Mayo Clinic; University of Alabama at Birmingham; University of Southern California and other collaboratorsActive, not recruitingPancreatitis,Acute NecrotizingUnited States
-
University of OuluCopenhagen University Hospital, HvidovreUnknownAcute Necrotizing PancreatitisFinland
-
Sichuan Academy of Medical SciencesPeking Union Medical College HospitalCompleted
-
Interscope, Inc.CompletedAcute Pancreatitis | Necrotizing Pancreatitis | Acute Pancreatic NecrosisUnited States, Netherlands, Germany
Clinical Trials on Patient-controlled oral refeeding
-
Hospital Regional de Alta Especialidad del BajioCompleted
-
Consorci Sanitari del GarrafHospital Clinic of Barcelona; Hospital Universitari Joan XXIII de Tarragona.CompletedPancreatitis, AcuteSpain
-
Karolinska InstitutetStockholm Health Care ServicesRecruiting
-
University Hospital, AkershusCompletedAffective Disorder | Psychoses
-
University of Wisconsin, MadisonNational Institute of Nursing Research (NINR)CompletedPain | Cancer | Fatigue | Sleep DisturbanceUnited States
-
AirXpanders, Inc.CompletedBreast Cancer | Breast Reconstruction | MastectomyAustralia
-
Karolinska InstitutetCompletedAnorexia Nervosa | Bulimia Nervosa | Eating DisordersSweden
-
Memorial Sloan Kettering Cancer CenterCompletedPostoperative PainUnited States
-
National Taiwan University HospitalUnknown